Research Reports

Chemicals and Materials

icon
icon
Home » Reports » Low Dosage Hydrate Inhibitors Market
Market Research Report

Low Dosage Hydrate Inhibitors Market By Type (Anti-Agglomerate (AA) inhibitors, Kinetic Hydrate Inhibitors (KHI)); By End-User Industries (Oilfield Service Industries, Oil Drill & Production Industries, Gas generation and distribution Industries, Others) - Global Demand Analysis & Opportunity Outlook 2027

Published On : December, 2018 REP-ID-1029 Category: Chemicals and Materials

Global Low Dosage Hydrate Inhibitors Market Overview

Low dosage hydrate inhibitors are used during crude oil extraction processes to minimize hydrate formation in the systems, thus lowering the maintenance costs of drilling and refining systems used in crude oil and gas extraction industries. The advantage of using low dosage hydrate inhibitors in gas system’s life extension is expected to upsurge the demand among the manufacturers of crude oil products. Additionally, the capability to produce combination products by the use of low dosage hydrate inhibitors is estimated to increase the demand even more. Technologically advanced production process of low dosage hydrate inhibitors and on-going research and development activities is anticipated to gather more value of the low dosage hydrate inhibitors market.

Market Size & Forecast

Low Dosage Hydrate Inhibitors Market is anticipated to record a CAGR of 7.2% over the forecast period. Many multi-national companies are concentrating towards reducing maintenance costs by introducing low dosage hydrate inhibitors in oil and gas production procedures. Moreover, the many advantageous properties of low dosage hydrate inhibitors are exploited in the field of crude oil and gas generation now and then. Uses for low dosage hydrate inhibitors for lowering maintenance as well as logistical expenses in crude oil industries is expected to drive the low dosage hydrate inhibitors market rapidly.

Currently the global low dosage hydrate inhibitors market is observing vibrant growth owing to increasing demand of crude oil on account of increasing energy demand in the market. Advances in crude oil and gas extraction and generation industry in the past few years and growing industrialization is projected to drive low dosage hydrate inhibitors market besides the wide range of functions of low dosage hydrate inhibitors in system stability to minimizing environmental carbon footprints during the forecast period.

On the basis of regional platform, global Low Dosage Hydrate Inhibitors market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.

As a controller of hydrate formation in oil and gas industry, North America is panned to observe substantial low dosage hydrate inhibitors market growth due to rising low dosage hydrate inhibitors usage. North America is predicted to be followed by Europe in terms of crude oil consumption due to expanding industrialization and increasing requirements of generators maintenance in crude oil and gas extraction industries.

Asia Pacific is expected to drive demand and positively impact low dosage hydrate inhibitors market growth over the forecast period on account of increasing low dosage hydrate inhibitors application for extraction, refining and purification process of crude oil. Due to multiplying power production industries with rising energy demand in growing end-use industries, Asia Pacific is budding as a regional low dosage hydrate inhibitors and its derivatives consumption market.

Low Dosage Hydrate Inhibitors Market size

Market Segmentation

Our-in depth analysis of the global Low Dosage Hydrate Inhibitors market includes the following segments:

By Type

  • Anti-Agglomerate (AA) inhibitors
  • Kinetic Hydrate Inhibitors (KHI)
    • Polymers
    • Co-Polymers

By End-User Industries

  • Oilfield Service Industries
  • Oil Drill & Production Industries
  • Gas generation and distribution Industries
  • Others

By Region

Global Low Dosage Hydrate Inhibitors Market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of Asia) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Low Dosage Hydrate Inhibitors Market

Growth Drivers & Challenges

The rising demand for low dosage hydrate inhibitors for controlling gas hydrate formation in oil and gas industries are expected to drive the market rapid over the forecast period. The growing R&D activity associated to low dosage hydrate inhibitors is further expected to increase the market growth owing to the discovery of new applications of it on regular basis. Several factors such as reduction in logistical costs along with environmental footprint minimization are expected to drive the market at a robust rate. Additionally, better operation under critical temperature conditions and low toxicity with increased compatibility of fluid systems with the help of low dosage hydrate inhibitors is estimated contribute significantly in the upsurge of demand for low dosage hydrate inhibitors during the forecast period. Moreover, increase in stability of the systems by reduction in depressurization in pipelines by the use of low dosage hydrate inhibitors during cold seasons is further anticipated to increase the requirement for low dosage hydrate inhibitors across the countries with predominant cold weathers as well as in developed and developing countries over the forecast period. The significant cost saving on account of low gas hydrate formation issues by the application of low dosage hydrate inhibitors is anticipated to create a steady upsurge in demand for low dosage hydrate inhibitors around the globe. Furthermore, the use of low dosage hydrate inhibitors allow for combination products generation which is predicted to expand the market of low dosage hydrate inhibitors over the forecast period. Growing industrialization along with increasing crude oil and gas consumption with manufacturers aiming for higher profit by lowering maintenance costs is expected to behave as the key factor in the growth of the low dosage hydrate inhibitors market.

However, presence of cheaper alternatives in the market is predicted to behave as a major factor in the growth of low dosage hydrate inhibitors market over the forecast period.

Key Players

  • Ashland
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Halliburton
  • NALCO
  • NEFTECHIM Technologies
  • GasHydrate LLC
  • Evonik
  • Ecolab
  • Clariant Chemicals
  • Yara International
  • Stella Maris LLC
  • BASF

things to know

SELECT LICENSE TYPE

KEY BENEFITS

  • DIRECT ANALYST ASSISTANCE

    Direct access to analyst to help you understand the market in a better way to handle your critical question

  • CUSTOMIZE AS PER YOUR NEED

    Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved

  • DISCOUNT ON CUSTOMISATION

    Get 10% free customization

  • QUALITY ASSURED

    Great focus on accuracy and quality of the research

Connect With Us

Call us

(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495
Email: info@researchnester.com

RELATED REPORTS

Delivery Center

Ansal Corporate Park, Plot no 7A/1,
Tower A1,
Sector 142 Noida., 201301 India
info@researchnester.com

US Office

77 Water Street 8th Floor,
New York, New York, 10005
Phone : +1 646 586 9123
info@researchnester.com

Canada (Toronto)

Phone : +1 437 889 3230
info@researchnester.com


UK Office (London)

Phone : +44 203 608 5919
info@researchnester.com

Subscribe To Our Newsletters

Copyright © 2018 Research Nester. All rights reserved

Top